Summary.-Antigenic determinants of p30, the most abundant internal virion protein of C type RNA viruses, were detected on the surface of spleen cells from mice bearing Moloney leukaemia and on an in vitro line of Moloney sarcoma, MSC. On both cell types, these determinants on the p30 molecules served as cytotoxic targets in a xenogeneic complement dependent antibody mediated 51Cr release assay. Two antisera were used: a rat anti MLV-M induced lymphoma serum, and an antiserum raised in goats to ether disrupted FeLV. The cytotoxic target antigens of these antisera were analysed by inhibition of cytotoxicity with viral and cellular proteins. p3Ot is the most abuindant internal protein of murine leukaemia and sarcoma viruses (MLV, AMSV), since it comprises 30%o of the total viral protein (Gilden, Oroszlan and Huebner, 1971) . It has a molecular weignt of approximately 30,000 daltons and is thought to be associated with-t the core shell of the virus (Bolognesi, Luftig and Shaper, 1973) . Both type and group specific (gs) antigenic determinants have been identified on the p30 molecule (Gilden et al., 1971; Parks and Scolnick, 1972; Strand and August, 1974) . The gs determinants have been further subdivided into a species specific (gsl) and an interspecies specific determinant (gs3) (Gilden et al., 1971) . Yoshiki, Mellors and Hardy (1973) , using indirect membrane immunofluorescence, detected a common cell surface antigen associated with murine and feline C type RNA leukaemia viruses in cells infected or transformed by such viruses. In these studies the authors employed an antiserum prepared by the immunization of rabbits with ether disrupted feline leukaemia virus (FeLV) . They suggested that the common cell surface antigen which they detected with this antiserum was p30, since this antigen was the only subviral component to absorb the antibody activity against the common cell surface antigen. In further immunofluorescence studies both the gs1 and gs3 antigenic determinants were detected on the surface of leukaemic cells and tissue culture lines infected with C type RNA viruses (Yoshiki et al., 1974) .
Further evidence that p30 is expressed on the surface of mouse leukaemia cells has been obtained from experiments using xenogeneic cytotoxic antisera. Serum from guinea-pigs hyperimmunized with pure p30 is cytotoxic, in the presence of complement, for mouse cells infected with either Radiation leukaemia virus, or the Gross and Moloney strains of MLV, but not for the nonviral mnouse leukaemia ERLD (Ferrer, 1973) . Although mice do not produce anti-p30
antibodies (Geering, Old and Boyse, 1966) , there is evidence that immune mouse lymphocytes recognize the antigen. Thus, p30 inhibits cell mediated cytotoxicity towards MLV target cells (Gorczynski and Knight, 1975a) and can stimnulate blast transformation by MSV immune lymphocytes (Knight and Gorczynski, 1975) . Furthermore, lymphoid cells activated in vitro to p30 are able, on adoptive transfer, to reduce the number of lethal MSV tumours in sublethally irradiated syngeneic recipient mice (Gorczynski and Knight, 1975b) .
The purpose of the present study was to compare the expression of the gs1 and gs3 antigenic determinants of p30 on mouse cells infected or transformed by MLV or MSV, using a xenogeneic cytotoxic antibody assay. The identification of p30 in leukaemic mouse sera and the relevance of circulating p30 to the tumour status of the animal are discussed in the following paper by Epstein and Knight (1975) . The results obtained here confirm and extend those previously reported with MLV-G induced lymphomata in the rat (Knight, Mitchison and Shellam, 1975 (Massicot et al., 1971) . , and diluted 1: 3, making the final dilution in the assay of 1: 9. Antisera 1. Rat ILR-3.-This antiserum was prepared in W/Fu rats against syngeneic MLV-M induced-lymphoma cells as described previously . On Ouchterlony gel diffusion a precipitin line was formed with this antiserum and p30, and with disrupted MLV-M, but not with hamster sarcoma virus (HSV).
2. Goat Anti-gs3.-This antiserum was prepared in goats against a preparation of ether disrupted FeLV. It was a gift from Professor William Jarrett, University of Glasgow, Glasgow. Additional details of its preparation and characterization have been described previously (Jarrett et al., 1973; Knight, Mitchison and Shellam, 1975 (Knight and Gorczynski, 1975) . Because of sensitivity of viral particles to freezing and thawing, it is possible that intact virus preparations also contain some internal virion proteins. Newcastle Disease virus (NDV) was a gift from Dr J. Skehel, National Institute of Medical Research, Mill Hill, London, England. Disrupted virus preparations were prepared either by 12 cycles of repeated freezing and thawing, or by Triton X-100 treatment followed by partition in ether as previously described (Knight and Gorczynski, 1975) . The amount of protein was determined by the method of Lowry et al. (1951) , or by the ratio of optical density at 280/260 nm using u.v.
2. p3O.-p30 was prepared by an isoelectric focusing method described previously (Scolnick, Parks and Livingston, 1972 Meltzer et al.(1971) .
4. Leukaemic and normal BALB/c spleen cell preparations.-Single cell suspensions were prepared from pools of 2-3 leukaemic or normal animals, by teasing, filtration through stainless steel mesh and twice washing with E-4-G1. The cells were packed at 1500 rev/ min for 10 min for use in absorption of antisera.
5. Method ofabsorption.-Varying amounts of the absorbents, i.e. either intact or disrupted virus, purified viral antigens, or KCI extracts of viral infected cells, were combined with the undiluted antisera to be absorbed, and sufficient E-4-G1 with 10% normal serum to make a final volume of 0-1 ml. This would result in the dilution of the antiserum desired for use in the cytotoxicity assay. Consequently, in most instances, 10-20 ,u of antiserum were used, 10-70 ,ul absorbent, and the remainder was E-4-G1. The mixtures were maintained at room temperature for 30 min and then used in the cytotoxicity assays. Control preparations containing only the absorbents and on antisera were also included to exclude any possible cytotoxic or anticomplementary effects of the absorbents.
When antisera were absorbed with normal or leukaemic spleen cells, in some instances 250 ,ul of 1/5 dilutions of antisera were combined with 50 pl packed cells and incubated at 3700 for 30 min on a rotator. The cells were then pelleted at 2000 rev/min for 4 min. The procedure was repeated for a second absorption. On other occasions a fixed number of leukaemic or normal spleen cells was employed for the absorptions. Cytotoxicity assay 1. 5'Cr labelling.-The technique employed was that described by withthefollowingmodification. 1 x 108 viable spleen cells from Moloney leukaemia bearing mice, or 1 x 107 viable MSC cells were suspended in 1 ml of Hepes buffered MEM with 10% heat inactivated FCS in 30 mm plastic Petri dishes and incubated with 100 ,Ci of 5'Cr (as Na chromate in aqueous solution: specific activity of 250 /Ci/ ,ug, The Radiochemical Centre, Amersham) at 3700 for 1 h with gentle agitation on a rocking platform. The cells were spun at 1000 rev/min and washed 3 times with 40 ml of fresh media. The labelled spleen cells were resuspended at 5 x 106 viable cells/ml and the labelled MSC cells at 1 X 106 viable cells/ml.
2. Assay.-The assay was performed in 2 x i in glass tubes (United Glass London), as described previously . Serial dilutions (0-1 ml) of antisera to be tested were made in E-4-G1 media containing 10% heat inactivated normal serum of the same species from which the antiserum was derived. To this was added either 0.1 ml of the 51Cr labelled spleen cells (5 X 105) or MSC cells (1 X 105), and 0-1 ml rabbit complement diluted 1: 3 with E-4-G1. The following controls were included in each assay: (1) 51Cr labelled cells and 0-2 ml E-4-G1 to determine total amount of label and amount of spontaneous release; (2) 6lCr labelled cells plus 0-2 ml 5% there was less 51Cr release than in the control tuibes containing 100% normal rat serum andl rabbit complement, but still more than the sponitanieous release. Fig. 1 The block of cytotoxic activity of ILR-3 for MSC targets was not unique for MSV-M, however. Other related C type RNA viruses, MSV-G and MLV-G, as well as KCI extracts of mouse embryo tissue culture lines infected with MSV-G and MSV-M, could absorb the cytotoxic antibodies in Rat ILR-3, and the data are depicted in Fig. 5 . In these experiments, Cytotoxicity studies with monospeciftc antisera To confirm the presence of specific viral antigens on the surface of the M leukaemia spleen cell and MSC targets, monospecific antisera were employed. Figure 6 depicts the results of 2 experiments in which the % specific cytotoxicity of rat anti-formol MSV-M serum for M leukaemia spleen cell targets was studied. In the presence of rabbit complement, cytotoxicity was observed against cells obtained 7 and 12 days after passage of the leukaemia, but higher dilutions of the antiserum were more cytotoxic for the Day 7 cells than for the Day 12 cells.
In subsequent experiments, antisera directed against internal virion proteins were studied. Figure 7 illustrates a representative experiment in which goat antigs3 was shown to be cytotoxic for MSC target cells in the presence of rabbit complement. Goat anti-gs3 was also cytotoxic for M leukaemia spleen cell targets, although to a lesser degree than was observed with MSC targets. For example, in 4 experiments with M targets the mean % cytotoxicity at a dilution of 1/5 was 16%; at 1/10, 13%; at 1/20, 11%, at 1/40, 1%. A comparison was then made between the % specific cytotoxicity observed before and after absorption of the goat anti-gs3 with either normal BALB/c spleen cells or M leukaemia spleen cells, the latter obtained at 4, 8 and 12 days after the passage of the leukaemia. The results, shown in Fig. 8 , indicate that spleen cells obtained from the leukaemic animals could absorb out the anti-gs3 cytotoxic antibodies, but that normal spleen cells could not. It was of interest to note that spleen cells obtained 8 days after the passage of leukaemia were superior to those obtained either after 4 or 12 days, as in the former instance most of the anti gs3 activity was absorbed with only 105 cells, whereas in the latter 2 instances more cells were required.
Absorption studies with purified viral proteins
Several experiments were performed to substantiate the role of p30 as a cyto- resulted in 43% block of the cytotoxic activity of the antiserum. Yet, increasing the amount of p30 used for the absorption by 70-fold, i.e. to 12-6 6,g still did not result in 100% absorption of cytotoxic activity.
Absorption of ILR-3 antibody with 3-6 ,ug p3U produced 64% block of cytotoxicity against MSC targets. However, the same amount of antigen inhibited lysis of M leukaemia spleen cell targets by ILR-3 by only 16%. On both cell targets ILR-3 is recognizing p30, although it would appear that even on MSC cells its cytotoxicity is not directed exclusively to this antigen.
The goat anti-gs3 antiserum was cytotoxic for both MSC and M leukaemia cell targets, although the % specific cytotoxicity of leukaemic cells was low. Correspondingly, as little as 0-18 ,ug purified p30 totally absorbed cytotoxicity against leukaemic cells, whereas only 20% of the cytotoxicity against MSC cells was absorbed by 9-0 ag purified p30.
p30 was not effective in absorbing cytotoxic activity of rat anti-formol MSV-M, suggesting that the absorption of other antisera by p30 is a specific event. The cytotoxicity of the rat anti-formol MSV-M confirms the presence of cytotoxic targets other than p30 on the surface of leukaemic cells.
To The present study demonstrates that p30, the most abundant internal virion protein of C type RNA viruses, is associated with the surface on both these cell types, in that group specific antigenic determinants on the p30 molecule were shown to act as cytotoxic targets in xenogeneic complement dependent antibody mediated cytotoxicity reactions.
For this study we employed an antiserumn prepared in rats against a syngeneic AILV-MI lymphoma (ILR-3) and one prepared in goats against an ether disrupted preparation ofFeLV (goat anti-gs3). Absorption of each of these antisera with normal BALB3c mouse spleen cells resulted inl no loss of cytotoxic activity, thus indicatinig that the cytotoxic antibodies present in these sera were directed to antigenic determinants other than those found on normal murine cells. This observation, coupled with the fact that absorption of each antiserum with Moloney leutkaemia spleen cells from age and sex matched BALB/c mice resulte(I in complete loss of cytotoxic antibody activity, indicated that such antibodies were directed toward leukaemia associated antigens.
Further absorption studies with Rat ILR-3 revealed the following information about the cytotoxic antibodies contained therein: (1) obtained from MSV-M as highly purified preparations of this protein were effective in absorbing cytotoxic antibody activity of ILR-3 against both M leukaemia spleen cell and MSC targets.
Confirmatory evidence that p30 is associated with the surface membranes of both cell types was obtained with the goat anti-gs3 serum. It was cytotoxic for both cell types and its cytotoxic antibody activity could be partially blocked by purified preparations of p30. It is possible that the antigenic determinants of p30 are more abundant or more accessible on the surface of MSC cells than on M leukaemia target cells, as there was more specific cytotoxicity for the former than the latter. Also, a given amount of p30 blocked the cytotoxicity of this antiserum for M targets more readily than MSC, despite the fact that 5 times as many Al targets were employed as MSC. There is also suggestive evidence that the amount or accessibility of the anitigeniic deter- It is unlikely that the presence of p30 on viral infected or transformed cells represents simple adsorption of the viral protein to the surface membranes of cells. In the present study, target cells were washed 4-5 times before use in the cytotoxic assay and still the antigenic determinants of p30 were detectable as cytotoxic targets. Furthermore, Yoshiki et al. (1973 Yoshiki et al. ( , 1974 have demonstrated with immunoelectron microscopic techniques that p30 is located on cell membranes near the site of virus budding but at a locations distinct from that of VEA. They then showed with immunofluorescence that an antigenic determinant of p30 can actually cap with monospecific antisera, thus indicating an intimate relationship of the p30 molecule with the fluid membrane of C-type RNA virus infected cells.
Despite the fact that considerable cytotoxicity was observed in the present study with the goat anti-gs3 for MSC cells, we were unable to produce more than 14% specific lysis of MSC cells or any lysis of MI leukaemia spleen cells with a rabbit antibody raised to purified p30 an1d which recognized solely the gs, determinant.
It would appear then that in the mouse differential expression of gs, and gs3 antigenic determinants of p30 occurs. This is not true for the rat, where the same goat anti-gs3 and rabbit anti-gs, sera employed in the present study gave equal amounits of cytotoxicity when tested against rat G lymphoma cells (Ferrer, 1973) .
The results of the present studv are in agreement with this, as are our recent studies which showed total block of the cytotoxicity of rat anti-Gross lymphoma sera for syngeneic target cells by p30 (Knight and Gorczynski, 1975; . A manuscript to follow also offers confirmatory evidence, as in it we demonstrate that Moloney leukaemic serum contains p30 and also absorbs the cytotoxic activity of Rat ILR-3 against MSC and M target cells (Epstein and Knight, 1975) .
